Cargando…

Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study

BACKGROUND: The role of an episode of acute kidney injury (AKI) in long-term mortality among initial survivors of critical illness is controversial. We aimed to determine whether AKI is independently associated with decreased survival at 3 years among 30-day survivors of intensive care. RESULTS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Mildh, Henriikka, Pettilä, Ville, Korhonen, Anna-Maija, Karlsson, Sari, Ala-Kokko, Tero, Reinikainen, Matti, Vaara, Suvi T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Paris 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127925/
https://www.ncbi.nlm.nih.gov/pubmed/27900737
http://dx.doi.org/10.1186/s13613-016-0218-5
_version_ 1782470310924124160
author Mildh, Henriikka
Pettilä, Ville
Korhonen, Anna-Maija
Karlsson, Sari
Ala-Kokko, Tero
Reinikainen, Matti
Vaara, Suvi T.
author_facet Mildh, Henriikka
Pettilä, Ville
Korhonen, Anna-Maija
Karlsson, Sari
Ala-Kokko, Tero
Reinikainen, Matti
Vaara, Suvi T.
author_sort Mildh, Henriikka
collection PubMed
description BACKGROUND: The role of an episode of acute kidney injury (AKI) in long-term mortality among initial survivors of critical illness is controversial. We aimed to determine whether AKI is independently associated with decreased survival at 3 years among 30-day survivors of intensive care. RESULTS: We included 2336 30-day survivors of intensive care enrolled in the FINNAKI study conducted in seventeen medical–surgical ICUs in Finland during a 5-month period in 2011–2012. The incidence of AKI, defined by the Kidney Disease: Improving Global Outcomes criteria, was 34.6%, and 192 (8.3%) commenced RRT. The 3-year mortality among AKI patients was 23.5% (95% CI 20.6–26.4%) compared to 18.9% (17.0–20.9%) of patients without AKI, p = 0.01. However, after adjustments using Cox proportional hazards regression, AKI was not associated with decreased 3-year survival (HR 1.05; CI 95% 0.86–1.27), whereas advanced age, poor pre-morbid functional performance, and presence of several comorbidities were. Additionally, we matched AKI patients to non-AKI patients 1:1 according to age, gender, presence of severe sepsis, and a propensity score to develop AKI. In the well-balanced matched cohort, 3-year mortality among AKI patients was 136 of 662 (20.5%; 17.5–23.6%) and among matched non-AKI patients 143 of 662 (21.6%; 18.5–24.7%), p = 0.687. Neither AKI nor RRT was associated with decreased survival at 3 years in the sensitivity analyses that excluded patients (1) with chronic kidney disease, (2) with AKI not commenced renal replacement therapy (RRT), and (3) with estimated pre-admission creatinine, chronic kidney disease, or AKI stage 1. CONCLUSION: AKI was not an independent risk factor for 3-year mortality among 30-day survivors. Increased 3-year mortality among patients with AKI who survive critical illness may not be related to AKI per se, but rather to advanced age and pre-existing comorbidities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0218-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5127925
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Paris
record_format MEDLINE/PubMed
spelling pubmed-51279252016-12-19 Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study Mildh, Henriikka Pettilä, Ville Korhonen, Anna-Maija Karlsson, Sari Ala-Kokko, Tero Reinikainen, Matti Vaara, Suvi T. Ann Intensive Care Research BACKGROUND: The role of an episode of acute kidney injury (AKI) in long-term mortality among initial survivors of critical illness is controversial. We aimed to determine whether AKI is independently associated with decreased survival at 3 years among 30-day survivors of intensive care. RESULTS: We included 2336 30-day survivors of intensive care enrolled in the FINNAKI study conducted in seventeen medical–surgical ICUs in Finland during a 5-month period in 2011–2012. The incidence of AKI, defined by the Kidney Disease: Improving Global Outcomes criteria, was 34.6%, and 192 (8.3%) commenced RRT. The 3-year mortality among AKI patients was 23.5% (95% CI 20.6–26.4%) compared to 18.9% (17.0–20.9%) of patients without AKI, p = 0.01. However, after adjustments using Cox proportional hazards regression, AKI was not associated with decreased 3-year survival (HR 1.05; CI 95% 0.86–1.27), whereas advanced age, poor pre-morbid functional performance, and presence of several comorbidities were. Additionally, we matched AKI patients to non-AKI patients 1:1 according to age, gender, presence of severe sepsis, and a propensity score to develop AKI. In the well-balanced matched cohort, 3-year mortality among AKI patients was 136 of 662 (20.5%; 17.5–23.6%) and among matched non-AKI patients 143 of 662 (21.6%; 18.5–24.7%), p = 0.687. Neither AKI nor RRT was associated with decreased survival at 3 years in the sensitivity analyses that excluded patients (1) with chronic kidney disease, (2) with AKI not commenced renal replacement therapy (RRT), and (3) with estimated pre-admission creatinine, chronic kidney disease, or AKI stage 1. CONCLUSION: AKI was not an independent risk factor for 3-year mortality among 30-day survivors. Increased 3-year mortality among patients with AKI who survive critical illness may not be related to AKI per se, but rather to advanced age and pre-existing comorbidities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0218-5) contains supplementary material, which is available to authorized users. Springer Paris 2016-11-29 /pmc/articles/PMC5127925/ /pubmed/27900737 http://dx.doi.org/10.1186/s13613-016-0218-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Mildh, Henriikka
Pettilä, Ville
Korhonen, Anna-Maija
Karlsson, Sari
Ala-Kokko, Tero
Reinikainen, Matti
Vaara, Suvi T.
Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
title Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
title_full Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
title_fullStr Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
title_full_unstemmed Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
title_short Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
title_sort three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational finnaki study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127925/
https://www.ncbi.nlm.nih.gov/pubmed/27900737
http://dx.doi.org/10.1186/s13613-016-0218-5
work_keys_str_mv AT mildhhenriikka threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy
AT pettilaville threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy
AT korhonenannamaija threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy
AT karlssonsari threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy
AT alakokkotero threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy
AT reinikainenmatti threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy
AT vaarasuvit threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy
AT threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy